European Commission gives nod to Novartis’ novel therapy to treat breast cancer – Healthcare News
Novartis on Wednesday announced that the European Commission (EC) has approved Kisqali (ribociclib) for the treatment of early breast cancer...
Novartis on Wednesday announced that the European Commission (EC) has approved Kisqali (ribociclib) for the treatment of early breast cancer...